Steven Artandi, M.D., Ph.D. was appointed director of the Stanford Cancer Institute — an initiative that aims to improve cancer treatment at Stanford — on Oct. 1. He was previously a professor of medicine and biochemistry at the School of Medicine and will succeed outgoing director Beverly Mitchell, M.D., who has led the Institute for the past 10 years.
The Stanford Cancer Institute (SCI) received recognition as a “comprehensive cancer center,” the highest cancer center designation, on July 1. The National Cancer Institute (NCI) awards this designation to cancer centers with excellent research, as well as connection and interaction across research areas, according to SCI director and professor in medicine Beverly Mitchell.
A team of Stanford researchers has been studying the qualities of collagen, a protein in the human body that both cushions and protects living tissue by altering its fluidity and elasticity. A Stanford News article published yesterday detailed the findings of the researchers and also likened collagen to Silly Putty through its unique characteristics, which could enable collagen to usher in a variety of developments in regenerative medical research.
The Stanford Cancer Institute (SCI) and SRI Biosciences, a division of the independent research center SRI International, are partnering up to enhance drug development efforts in response to a lack of innovative new treatments for cancer and other diseases.
On Friday, June 26, Stanford Health Care held a ribbon-cutting ceremony for its new South Bay Cancer Center in San Jose. Over 250 physicians, Stanford employees and community members attended the event, which included speeches and a tour of the building.
Researchers at the Stanford Cancer Institute and the Cancer Prevention Institute of California (CPIC) have laid the groundwork for a comprehensive database that will contribute to earlier detection of cancer through blood tests, through soliciting tens of thousands of blood samples.
Stanford Hospitals & Clinics announced plans last week to build a new outpatient cancer center in San Jose. The center, which will be completed in 2014, will be Stanford healthcare system’s most comprehensive facility outpatient center other than of Palo Alto’s Stanford Hospital & Clinics and Redwood City’s Stanford Medicine Outpatient Center, according to a release from the Stanford Hospital.
The Stanford Cancer Institute opened a new clinic this week with the intention of providing better care for patients after cancer treatment. The clinic, which will initially to be open only to gynecologic cancer survivors, will focus on assisting patients through issues such as fatigue, anxiety, body image, sexual function and relationships, according to a press release from the Stanford School of Medicine.